Shionogi & Co., Ltd.

Shionogi & Co., Ltd. is a prominent pharmaceutical company originating from Japan, specializing in research, development, and commercialization of medicines. Its central focus is on addressing infectious diseases, with a strong dedication to innovating treatments and preventative measures for conditions like HIV/AIDS and influenza. Additionally, Shionogi is involved in the development of antibiotics and vaccines, aiming to tackle global health challenges such as drug-resistant bacterial infections. The company's portfolio also includes therapeutic solutions for pain management, central nervous system disorders, and oncology. As a key player within the pharmaceutical sector, Shionogi's contributions play a critical role in public health, particularly in the Asian market, where it holds significant influence. With its foundations laid in 1878, Shionogi continues to be an innovator within its field, broadening its impact and collaborating on a global scale to enhance quality of life through effective and advanced healthcare solutions. Its efforts in research and development underscore its commitment to providing cutting-edge healthcare products that address both emerging and persistent medical needs worldwide.